Despite the current treatment of heart failure including beta blockers, aldosterone receptor antagonists, cardiac enhancers, diuretics, and more, readmission and mortality rates are still high, placing a huge medical burden on society, and the search for new treatment strategies to prevent and delay heart failure is urgent (2). This evidence concerns the gene NR3C2 and heart failure.